Melissa Kelly Behrs, SVP Oncology at GERON CORP (GERN), sold 8,861 shares at $4.90 ($43K) on 2009-01-05, disclosed to the SEC on 2009-01-06.
Seasonal sale ($43k) by SVP Oncology — this insider has traded GERN in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| GERN | SELL | 2014-05-30 | $10K | — | Filing → |
| GERN | SELL | 2014-04-02 | $26K | — | Filing → |
| GERN | SELL | 2013-01-22 | $47K | — | Filing → |